Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Low prevalence of known pathogenic mutations in dominant PD genes: A Swedish multicenter study.

Puschmann A, Jiménez-Ferrer I, Lundblad-Andersson E, Mårtensson E, Hansson O, Odin P, Widner H, Brolin K, Mzezewa R, Kristensen J, Soller M, Rödström EY, Ross OA, Toft M, Breedveld GJ, Bonifati V, Brodin L, Zettergren A, Sydow O, Linder J, Wirdefeldt K, Svenningsson P, Nissbrandt H, Belin AC, Forsgren L, Swanberg M.

Parkinsonism Relat Disord. 2019 Sep;66:158-165. doi: 10.1016/j.parkreldis.2019.07.032. Epub 2019 Jul 31.

2.

The Fat Mass and Obesity-Associated Protein (FTO) Regulates Locomotor Responses to Novelty via D2R Medium Spiny Neurons.

Ruud J, Alber J, Tokarska A, Engström Ruud L, Nolte H, Biglari N, Lippert R, Lautenschlager Ä, Cieślak PE, Szumiec Ł, Hess ME, Brönneke HS, Krüger M, Nissbrandt H, Korotkova T, Silberberg G, Rodriguez Parkitna J, Brüning JC.

Cell Rep. 2019 Jun 11;27(11):3182-3198.e9. doi: 10.1016/j.celrep.2019.05.037.

3.

Testosterone is an endogenous regulator of BAFF and splenic B cell number.

Wilhelmson AS, Lantero Rodriguez M, Stubelius A, Fogelstrand P, Johansson I, Buechler MB, Lianoglou S, Kapoor VN, Johansson ME, Fagman JB, Duhlin A, Tripathi P, Camponeschi A, Porse BT, Rolink AG, Nissbrandt H, Turley SJ, Carlsten H, Mårtensson IL, Karlsson MCI, Tivesten Å.

Nat Commun. 2018 May 25;9(1):2067. doi: 10.1038/s41467-018-04408-0.

4.

S100B polymorphisms are associated with age of onset of Parkinson's disease.

Fardell C, Zettergren A, Ran C, Carmine Belin A, Ekman A, Sydow O, Bäckman L, Holmberg B, Dizdar N, Söderkvist P, Nissbrandt H.

BMC Med Genet. 2018 Mar 12;19(1):42. doi: 10.1186/s12881-018-0547-3.

5.

Risk factors in Swedish young men for amyotrophic lateral sclerosis in adulthood.

Åberg M, Nyberg J, Robertson J, Kuhn G, Schiöler L, Nissbrandt H, Waern M, Torén K.

J Neurol. 2018 Mar;265(3):460-470. doi: 10.1007/s00415-017-8719-1. Epub 2017 Dec 28.

6.

Glucagon-Like Peptide 1 and Its Analogs Act in the Dorsal Raphe and Modulate Central Serotonin to Reduce Appetite and Body Weight.

Anderberg RH, Richard JE, Eerola K, López-Ferreras L, Banke E, Hansson C, Nissbrandt H, Berqquist F, Gribble FM, Reimann F, Wernstedt Asterholm I, Lamy CM, Skibicka KP.

Diabetes. 2017 Apr;66(4):1062-1073. doi: 10.2337/db16-0755. Epub 2017 Jan 5.

7.

Sustained Effects of Neonatal Systemic Lipopolysaccharide on IL-1β and Nrf2 in Adult Rat Substantia Nigra Are Partly Normalized by a Spirulina-Enriched Diet.

Patil J, Matte A, Nissbrandt H, Mallard C, Sandberg M.

Neuroimmunomodulation. 2016;23(4):250-259. doi: 10.1159/000452714. Epub 2016 Dec 9.

8.

No Association Between rs7077361 in ITGA8 and Parkinson's Disease in Sweden.

Ran C, Mehdi RN, Fardell C, Xiang F, Nissbrandt H, Sydow O, Wirdefeldt K, Belin AC.

Open Neurol J. 2016 Jun 30;10:25-9. doi: 10.2174/1874205X01610010025. eCollection 2016.

9.

Strong association between glucocerebrosidase mutations and Parkinson's disease in Sweden.

Ran C, Brodin L, Forsgren L, Westerlund M, Ramezani M, Gellhaar S, Xiang F, Fardell C, Nissbrandt H, Söderkvist P, Puschmann A, Ygland E, Olson L, Willows T, Johansson A, Sydow O, Wirdefeldt K, Galter D, Svenningsson P, Belin AC.

Neurobiol Aging. 2016 Sep;45:212.e5-212.e11. doi: 10.1016/j.neurobiolaging.2016.04.022. Epub 2016 May 3.

10.

GLP-1 is both anxiogenic and antidepressant; divergent effects of acute and chronic GLP-1 on emotionality.

Anderberg RH, Richard JE, Hansson C, Nissbrandt H, Bergquist F, Skibicka KP.

Psychoneuroendocrinology. 2016 Mar;65:54-66. doi: 10.1016/j.psyneuen.2015.11.021. Epub 2015 Dec 17.

11.

The Stomach-Derived Hormone Ghrelin Increases Impulsive Behavior.

Anderberg RH, Hansson C, Fenander M, Richard JE, Dickson SL, Nissbrandt H, Bergquist F, Skibicka KP.

Neuropsychopharmacology. 2016 Apr;41(5):1199-209. doi: 10.1038/npp.2015.297. Epub 2015 Oct 1.

12.

The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease.

Lill CM, Rengmark A, Pihlstrøm L, Fogh I, Shatunov A, Sleiman PM, Wang LS, Liu T, Lassen CF, Meissner E, Alexopoulos P, Calvo A, Chio A, Dizdar N, Faltraco F, Forsgren L, Kirchheiner J, Kurz A, Larsen JP, Liebsch M, Linder J, Morrison KE, Nissbrandt H, Otto M, Pahnke J, Partch A, Restagno G, Rujescu D, Schnack C, Shaw CE, Shaw PJ, Tumani H, Tysnes OB, Valladares O, Silani V, van den Berg LH, van Rheenen W, Veldink JH, Lindenberger U, Steinhagen-Thiessen E; SLAGEN Consortium, Teipel S, Perneczky R, Hakonarson H, Hampel H, von Arnim CAF, Olsen JH, Van Deerlin VM, Al-Chalabi A, Toft M, Ritz B, Bertram L.

Alzheimers Dement. 2015 Dec;11(12):1407-1416. doi: 10.1016/j.jalz.2014.12.009. Epub 2015 Apr 30.

13.

Fine mapping and resequencing of the PARK16 locus in Parkinson's disease.

Pihlstrøm L, Rengmark A, Bjørnarå KA, Dizdar N, Fardell C, Forsgren L, Holmberg B, Larsen JP, Linder J, Nissbrandt H, Tysnes OB, Dietrichs E, Toft M.

J Hum Genet. 2015 Jul;60(7):357-62. doi: 10.1038/jhg.2015.34. Epub 2015 Apr 9.

PMID:
25855069
14.

Differences in Anxiety-Like Behavior within a Batch of Wistar Rats Are Associated with Differences in Serotonergic Transmission, Enhanced by Acute SRI Administration, and Abolished By Serotonin Depletion.

Näslund J, Studer E, Pettersson R, Hagsäter M, Nilsson S, Nissbrandt H, Eriksson E.

Int J Neuropsychopharmacol. 2015 Feb 25;18(8). pii: pyv018. doi: 10.1093/ijnp/pyv018.

15.

Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson's disease - a multicenter study.

von Otter M, Bergström P, Quattrone A, De Marco EV, Annesi G, Söderkvist P, Wettinger SB, Drozdzik M, Bialecka M, Nissbrandt H, Klein C, Nilsson M, Hammarsten O, Nilsson S, Zetterberg H.

BMC Med Genet. 2014 Dec 12;15:131. doi: 10.1186/s12881-014-0131-4.

16.

Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism.

Francardo V, Bez F, Wieloch T, Nissbrandt H, Ruscher K, Cenci MA.

Brain. 2014 Jul;137(Pt 7):1998-2014. doi: 10.1093/brain/awu107. Epub 2014 Apr 22.

PMID:
24755275
17.

Dopamine signaling in the amygdala, increased by food ingestion and GLP-1, regulates feeding behavior.

Anderberg RH, Anefors C, Bergquist F, Nissbrandt H, Skibicka KP.

Physiol Behav. 2014 Sep;136:135-44. doi: 10.1016/j.physbeh.2014.02.026. Epub 2014 Feb 21.

PMID:
24560840
18.

Influence of ghrelin on the central serotonergic signaling system in mice.

Hansson C, Alvarez-Crespo M, Taube M, Skibicka KP, Schmidt L, Karlsson-Lindahl L, Egecioglu E, Nissbrandt H, Dickson SL.

Neuropharmacology. 2014 Apr;79:498-505. doi: 10.1016/j.neuropharm.2013.12.012. Epub 2013 Dec 24.

19.

Supportive evidence for 11 loci from genome-wide association studies in Parkinson's disease.

Pihlstrøm L, Axelsson G, Bjørnarå KA, Dizdar N, Fardell C, Forsgren L, Holmberg B, Larsen JP, Linder J, Nissbrandt H, Tysnes OB, Ohman E, Dietrichs E, Toft M.

Neurobiol Aging. 2013 Jun;34(6):1708.e7-13. doi: 10.1016/j.neurobiolaging.2012.10.019. Epub 2012 Nov 13.

PMID:
23153929
20.

Association of a protective paraoxonase 1 (PON1) polymorphism in Parkinson's disease.

Belin AC, Ran C, Anvret A, Paddock S, Westerlund M, Håkansson A, Nissbrandt H, Söderkvist P, Dizdar N, Ahmadi A, Anvret M, Willows T, Sydow O, Galter D.

Neurosci Lett. 2012 Jul 26;522(1):30-5. doi: 10.1016/j.neulet.2012.06.007. Epub 2012 Jun 13.

PMID:
22704918
21.

The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors.

Dickson SL, Shirazi RH, Hansson C, Bergquist F, Nissbrandt H, Skibicka KP.

J Neurosci. 2012 Apr 4;32(14):4812-20. doi: 10.1523/JNEUROSCI.6326-11.2012.

22.

Noisy galvanic vestibular stimulation promotes GABA release in the substantia nigra and improves locomotion in hemiparkinsonian rats.

Samoudi G, Nissbrandt H, Dutia MB, Bergquist F.

PLoS One. 2012;7(1):e29308. doi: 10.1371/journal.pone.0029308. Epub 2012 Jan 6.

23.

DJ-1 Mutations are Rare in a Swedish Parkinson Cohort.

Anvret A, Blackinton JG, Westerlund M, Ran C, Sydow O, Willows T, Håkansson A, Nissbrandt H, Belin AC.

Open Neurol J. 2011 Mar 22;5:8-11. doi: 10.2174/1874205X01105010008.

24.

Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease.

Francardo V, Recchia A, Popovic N, Andersson D, Nissbrandt H, Cenci MA.

Neurobiol Dis. 2011 Jun;42(3):327-40. doi: 10.1016/j.nbd.2011.01.024. Epub 2011 Feb 19.

PMID:
21310234
25.

Altered enzymatic activity and allele frequency of OMI/HTRA2 in Alzheimer's disease.

Westerlund M, Behbahani H, Gellhaar S, Forsell C, Belin AC, Anvret A, Zettergren A, Nissbrandt H, Lind C, Sydow O, Graff C, Olson L, Ankarcrona M, Galter D.

FASEB J. 2011 Apr;25(4):1345-52. doi: 10.1096/fj.10-163402. Epub 2010 Dec 16.

26.

Possible involvement of a mitochondrial translation initiation factor 3 variant causing decreased mRNA levels in Parkinson's disease.

Anvret A, Ran C, Westerlund M, Thelander AC, Sydow O, Lind C, Håkansson A, Nissbrandt H, Galter D, Belin AC.

Parkinsons Dis. 2010 Jun 14;2010:491751. doi: 10.4061/2010/491751.

27.

Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease.

von Otter M, Landgren S, Nilsson S, Celojevic D, Bergström P, Håkansson A, Nissbrandt H, Drozdzik M, Bialecka M, Kurzawski M, Blennow K, Nilsson M, Hammarsten O, Zetterberg H.

BMC Med Genet. 2010 Mar 2;11:36. doi: 10.1186/1471-2350-11-36.

28.

L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia.

Lindgren HS, Andersson DR, Lagerkvist S, Nissbrandt H, Cenci MA.

J Neurochem. 2010 Mar;112(6):1465-76. doi: 10.1111/j.1471-4159.2009.06556.x. Epub 2009 Dec 24.

29.

Motor activity-induced dopamine release in the substantia nigra is regulated by muscarinic receptors.

Andersson DR, Björnsson E, Bergquist F, Nissbrandt H.

Exp Neurol. 2010 Jan;221(1):251-9. doi: 10.1016/j.expneurol.2009.11.011. Epub 2009 Nov 26.

PMID:
19944096
30.

Kinesin light chain 1 gene haplotypes in three conformational diseases.

von Otter M, Landgren S, Nilsson S, Lundvall C, Minthon L, Bogdanovic N, Andreasen N, Gustafson DR, Skoog I, Wallin A, Håkansson A, Nissbrandt H, Zetterberg M, Tasa G, Blennow K, Zetterberg H.

Neuromolecular Med. 2010 Sep;12(3):229-36. doi: 10.1007/s12017-009-8103-0. Epub 2009 Nov 13.

PMID:
19911314
31.

Cytochrome P450 2E1 gene polymorphisms/haplotypes and Parkinson's disease in a Swedish population.

Shahabi HN, Westberg L, Melke J, Håkansson A, Belin AC, Sydow O, Olson L, Holmberg B, Nissbrandt H.

J Neural Transm (Vienna). 2009 May;116(5):567-73. doi: 10.1007/s00702-009-0221-1. Epub 2009 Apr 21.

PMID:
19381774
32.

Association of a polymorphism in the ABCB1 gene with Parkinson's disease.

Westerlund M, Belin AC, Anvret A, Håkansson A, Nissbrandt H, Lind C, Sydow O, Olson L, Galter D.

Parkinsonism Relat Disord. 2009 Jul;15(6):422-4. doi: 10.1016/j.parkreldis.2008.11.010. Epub 2009 Feb 3.

PMID:
19196542
33.

Do polymorphisms in transcription factors LMX1A and LMX1B influence the risk for Parkinson's disease?

Bergman O, Håkansson A, Westberg L, Belin AC, Sydow O, Olson L, Holmberg B, Fratiglioni L, Bäckman L, Eriksson E, Nissbrandt H.

J Neural Transm (Vienna). 2009 Mar;116(3):333-8. doi: 10.1007/s00702-009-0187-z. Epub 2009 Feb 3.

PMID:
19189040
34.

Cerebellar alpha-synuclein levels are decreased in Parkinson's disease and do not correlate with SNCA polymorphisms associated with disease in a Swedish material.

Westerlund M, Belin AC, Anvret A, Håkansson A, Nissbrandt H, Lind C, Sydow O, Olson L, Galter D.

FASEB J. 2008 Oct;22(10):3509-14. doi: 10.1096/fj.08-110148. Epub 2008 Jul 7.

PMID:
18606870
35.

PITX3 polymorphism is associated with early onset Parkinson's disease.

Bergman O, Håkansson A, Westberg L, Nordenström K, Carmine Belin A, Sydow O, Olson L, Holmberg B, Eriksson E, Nissbrandt H.

Neurobiol Aging. 2010 Jan;31(1):114-7. doi: 10.1016/j.neurobiolaging.2008.03.008. Epub 2008 Apr 16.

PMID:
18420308
36.

Escitalopram administered in the luteal phase exerts a marked and dose-dependent effect in premenstrual dysphoric disorder.

Eriksson E, Ekman A, Sinclair S, Sörvik K, Ysander C, Mattson UB, Nissbrandt H.

J Clin Psychopharmacol. 2008 Apr;28(2):195-202. doi: 10.1097/JCP.0b013e3181678a28.

PMID:
18344730
37.

Investigation of genes related to familial forms of Parkinson's disease--with focus on the Parkin gene.

Håkansson A, Belin AC, Stiller C, Sydow O, Johnels B, Olson L, Holmberg B, Nissbrandt H.

Parkinsonism Relat Disord. 2008 Aug;14(6):520-2. doi: 10.1016/j.parkreldis.2007.10.013. Epub 2008 Mar 5. No abstract available.

PMID:
18321758
38.

Cytochrome P450 2E1 in the substantia nigra: relevance for dopaminergic neurotransmission and free radical production.

Shahabi HN, Andersson DR, Nissbrandt H.

Synapse. 2008 May;62(5):379-88. doi: 10.1002/syn.20505.

PMID:
18288650
39.

Association study of two genetic variants in mitochondrial transcription factor A (TFAM) in Alzheimer's and Parkinson's disease.

Belin AC, Björk BF, Westerlund M, Galter D, Sydow O, Lind C, Pernold K, Rosvall L, Håkansson A, Winblad B, Nissbrandt H, Graff C, Olson L.

Neurosci Lett. 2007 Jun 15;420(3):257-62. Epub 2007 May 10.

PMID:
17537576
40.

S18Y in ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) associated with decreased risk of Parkinson's disease in Sweden.

Carmine Belin A, Westerlund M, Bergman O, Nissbrandt H, Lind C, Sydow O, Galter D.

Parkinsonism Relat Disord. 2007 Jul;13(5):295-8. Epub 2007 Feb 6.

PMID:
17287139
41.

Cyclooxygenase-2 polymorphisms in Parkinson's disease.

Håkansson A, Bergman O, Chrapkowska C, Westberg L, Belin AC, Sydow O, Johnels B, Olson L, Holmberg B, Nissbrandt H.

Am J Med Genet B Neuropsychiatr Genet. 2007 Apr 5;144B(3):367-9. Erratum in: Am J Med Genet B Neuropsychiatr Genet. 2008 Jun;147B(4):541.

PMID:
17171651
42.

Interleukin-6 gene polymorphism -174G/C influences plasma lipid levels in women.

Henningsson S, Håkansson A, Westberg L, Baghaei F, Rosmond R, Holm G, Ekman A, Nissbrandt H, Eriksson E.

Obesity (Silver Spring). 2006 Nov;14(11):1868-73.

43.

Placebo-controlled trial comparing intermittent and continuous paroxetine in premenstrual dysphoric disorder.

Landén M, Nissbrandt H, Allgulander C, Sörvik K, Ysander C, Eriksson E.

Neuropsychopharmacology. 2007 Jan;32(1):153-61. Epub 2006 Oct 11.

44.
45.
46.

Leucine-rich repeat kinase 2 (LRRK2) mutations in a Swedish Parkinson cohort and a healthy nonagenarian.

Carmine Belin A, Westerlund M, Sydow O, Lundströmer K, Håkansson A, Nissbrandt H, Olson L, Galter D.

Mov Disord. 2006 Oct;21(10):1731-4.

PMID:
16817197
47.

Investigation of genes coding for inflammatory components in Parkinson's disease.

Håkansson A, Westberg L, Nilsson S, Buervenich S, Carmine A, Holmberg B, Sydow O, Olson L, Johnels B, Eriksson E, Nissbrandt H.

Mov Disord. 2005 May;20(5):569-73.

PMID:
15648059
48.

A rare truncating mutation in ADH1C (G78Stop) shows significant association with Parkinson disease in a large international sample.

Buervenich S, Carmine A, Galter D, Shahabi HN, Johnels B, Holmberg B, Ahlberg J, Nissbrandt H, Eerola J, Hellström O, Tienari PJ, Matsuura T, Ashizawa T, Wüllner U, Klockgether T, Zimprich A, Gasser T, Hanson M, Waseem S, Singleton A, McMahon FJ, Anvret M, Sydow O, Olson L.

Arch Neurol. 2005 Jan;62(1):74-8.

PMID:
15642852
49.

Interaction of polymorphisms in the genes encoding interleukin-6 and estrogen receptor beta on the susceptibility to Parkinson's disease.

Håkansson A, Westberg L, Nilsson S, Buervenich S, Carmine A, Holmberg B, Sydow O, Olson L, Johnels B, Eriksson E, Nissbrandt H.

Am J Med Genet B Neuropsychiatr Genet. 2005 Feb 5;133B(1):88-92.

PMID:
15635591
50.

Association between the estrogen receptor beta gene and age of onset of Parkinson's disease.

Westberg L, Håkansson A, Melke J, Shahabi HN, Nilsson S, Buervenich S, Carmine A, Ahlberg J, Grundell MB, Schulhof B, Klingborg K, Holmberg B, Sydow O, Olson L, Johnels EB, Eriksson E, Nissbrandt H.

Psychoneuroendocrinology. 2004 Sep;29(8):993-8.

PMID:
15219649

Supplemental Content

Loading ...
Support Center